The Europe Hair Loss Treatment Products Market is supposed to record a compound annual growth rate (CAGR) of 3.6% during the forecast period of 2021 - 2026.
Hair loss has become a typical concern among people with the increasing pollution levels, work stress and other medical conditions. In order to combat this issue, several methods were proposed such as the use of hair loss treatment products. These products are clinically tested and approved by dermatologists to be applied on a regular basis. European consumers are among significant contributors to hair loss treatment products.
One of the major driving factors that help the growth of the Europe Hair Loss Treatment Products Market is the rising disposable income that led to increased purchasing power among local people. Changing fashion trends and rise in awareness of the availability of new, more effective, and safer hair loss products across the region is also among the driving factors of Europe Hair Loss Treatments Products business.
Increasing concerns among the people regarding the hair loss across the area especially among the females is one of the major driving factors that helps the market to grow further during the forecast period of 2021 to 2026. As per the report, the market of hair loss treatments products in Europe is determined to increase much further owing to aging population and changing lifestyle of consumers in this area.
Another significant driving factor of Europe Hair Loss Treatment Products Market is the high emphasis on appearances, increasing investments by the major players, and the increasing inclination towards the origin-specific ingredients across the customers in different nations of this area.
High cost of medication is one of the major restraints that is affecting the growth of the market of hair loss treatment products across the European region. Another considerable challenge to the growth of the market of hair loss treatment products is the presence of alternative treatment options such as hair transplant surgery, laser, light-based therapies, etc., which are proven to be effective.
The Europe Hair Loss Treatment Products Market is segmented on the basis of disease type, on the basis of sales channel, on the basis of end-use, and on the basis of region.
On the basis of disease type, the Europe Hair Loss Treatments Products market is segmented into Alopecia Areata, Cicatricial Alopecia, Traction Alopecia, Alopecia Totalis, Alopecia Universalis, Androgenetic Alopecia, and Others.
On the basis of distribution channel, the market of Europe Hair Loss Treatment Products Market is bifurcated into over-the-counter (OTC) and prescription-based. Among these, with the surge in online sales, the prescription-based segment is likely to hold the major share of the market in the foreseen years.
On the basis of end-use, the Europe Hair Loss Treatment Products Market is segmented into home care settings, dermatology clinics, and others. Among these, the dermatology clinics accounted for the prominent portion, which, however, is supposed to be dominated by homecare settings in the following years.
Based on the region, the European hair loss treatment products market is studied across the nations of Germany, France, Italy, UK, Spain, Norway, etc. Europe is expected to record an increase in the market share of Hair Loss Treatments Products owing to increased hair loss due to changing lifestyles and exposure to the environment, along with growing popularity of brands in various countries such as Germany. The increasing consumer per capita spending is also estimated to propel the growth of the market of Hair Loss Treatments Products in Europe in terms of revenue rate in the next few years.
Key market players:
Some of the key players operating in the European Hair Loss Treatments Products market are Concert Pharmaceuticals, Hcell Inc, Histogen Inc, Aclaris Therapeutics, Inc, Sun Pharmaceutical Industries Ltd, Merck & Co., Inc, Johnson & Johnson Services, Inc, and Glaxo Smith Kline Plc.
Coronavirus pandemic has affected the business mainly by directly affecting the production, creating supply chain disturbance and financial burden. This pandemic has impacted financially in every sector like restaurants, manufacturing units, flights, traveling and so on to halt their services.
Due to the COVID-19, Europe Hair Loss Treatment Products Market is also facing difficulties as several manufacturing industries have stopped production due to the financial crisis they had faced. As per the analysis, experts from the industry are predicting that the market will increase and will be back to the normal stage once the vaccine gets released. The local government has already lifted the lockdown in most of the countries and gave permission for the manufacturing companies to start their businesses with strict rules and regulations.
1.1 Market Definition
1.2 Scope of the report
1.3 Study Assumptions
1.4 Base Currency, Base Year and Forecast Periods
2. Research Methodology
2.1 Analysis Design
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Data Modelling
2.2.4 Expert Validation
2.3 Study Timeline
3. Report Overview
3.1 Executive Summary
3.2 Key Inferencees
4. Market Dynamics
4.1 Impact Analysis
4.2 Regulatory Environment
4.3 Technology Timeline & Recent Trends
5. Competitor Benchmarking Analysis
5.1 Key Player Benchmarking
5.1.1 Market share analysis
5.1.3 Regional Presence
5.2 Mergers & Acquistion Landscape
5.3 Joint Ventures & Collaborations
6. Market Segmentation
6.1 Hair Loss Treatment Products Market, By Disease Type 6.1.1 Alopecia Areata
6.1.2 Cicatricial Alopecia
6.1.3 Traction Alopecia
6.1.4 Alopecia Totalis
6.1.5 Alopecia Universalis
6.1.6 Androgenetic Alopecia
6.1.7 Market Size Estimations & Forecasts (2019-2024)
6.1.8 Y-o-Y Growth Rate Analysis
6.1.9 Market Attractiveness Index
6.2 Hair Loss Treatment Products Market, By End-Use
6.2.1 Homecare Settings
6.2.2 Dermatology Clinics
6.2.3 Market Size Estimations & Forecasts (2019-2024)
6.2.4 Y-o-Y Growth Rate Analysis
6.2.5 Market Attractiveness Index
6.3 Hair Loss Treatment Products Market, By Sales Channel
6.3.1 Over the Counter (OTC)
6.3.3 Market Size Estimations & Forecasts (2019-2024)
6.3.4 Y-o-Y Growth Rate Analysis
6.3.5 Market Attractiveness Index
7. Geographical Landscape
7.1 Global Identity Governance and Administration Market, by Region
7.2 North America - Market Analysis (2018 - 2024)
7.2.1 By Country
7.2.2 By Disease Type
7.2.3 By End-Use
7.2.4 By Sales Channel
7.3.1 By Country
18.104.22.168 Rest of Europe
7.3.2 By Disease Type
7.3.3 By End-Use
7.3.4 By Sales Channel
7.4 Asia Pacific
7.4.1 By Country
22.214.171.124 South Korea
126.96.36.199 South East Asia
188.8.131.52 Australia & NZ
184.108.40.206 Rest of Asia-Pacific
7.4.2 By Disease Type
7.4.3 By End-Use
7.4.4 By Sales Channel
7.5 Latin America
7.5.1 By Country
220.127.116.11 Rest of Latin America
7.5.2 By Disease Type
7.5.3 By End-Use
7.5.4 By Sales Channel
7.6 Middle East and Africa
7.6.1 By Country
18.104.22.168 Middle East
7.6.2 By Disease Type
7.6.3 By End-Use
7.6.4 By Sales Channel
8. Key Player Analysis
8.1 Histogen Inc.,
8.1.1 Business Description
8.1.4 SWOT Analysis
8.1.5 Recent Developments
8.1.6 Analyst Overview
8.2 Concert Pharmaceuticals Inc.
8.3 Dr. Reddy's Laboratories Ltd.
8.4 Alès Groupe
8.5 Merck & Co., Inc
8.6 Alpecin, Vitabiotics Ltd.
8.7 Sun Pharmaceutical Industries Ltd
8.9 Johnson and Johnson
8.11 Daiichi Sankyo, Inc.
8.12 Hcell Inc.
9. Market Outlook & Investment Opportunities
List of Tables
List of Figures